Soliton Inc, (SOLY), is a medical development company. It develops healthcare technological devices for medical and cosmetic treatments. The firm’s devices generate planar acoustic waves or shock waves in cosmetic surgical procedures, aesthetic surgical procedures, and dermatology procedures for treatments.
The shares of this company rose today because of positive results from it’s Pivotal Cellulite Clinical Trial. The company presented the results from its pivotal cellulite trial through a virtual video presentation at the American Academy of Dermatology (AAD) 2020 Virtual Meeting, held on June 12-14, 2020 online at the official AAD website.
Leading dermatologist, Dr. Elizabeth Tanzi, will present the results of Soliton’s pivotal cellulite study to participants at the AAD 2020 Virtual Meeting on June 12, 2020 at 3:00 pm EST. While only participants in the conference will be able to view the presentation to the AAD, the Company will post the trial results to its website concurrently with the presentation and will issue a press release regarding the results on June 15, 2020. Dr. Tanzi is a member of Soliton’s Scientific Advisory Board.
BlackRock reports $3.39 million position in Soliton Inc (SOLY)
BlackRock Inc. increased its position in Soliton Inc (NASDAQ:SOLY) by 1.2% in the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 418,046 shares of the company’s stock after buying an additional 4,985 shares during the period. BlackRock Inc. owned 2.47% of Soliton worth $3,386,000 at the end of the most recent reporting period.
Several other institutional investors and hedge funds have also recently modified their holdings of the company. Sunbelt Securities Inc. acquired a new position in Soliton during the 4th quarter valued at about $6,862,000. UBS Group AG boosted its stake in Soliton by 38.5% during the 4th quarter. UBS Group AG now owns 6,841 shares of the company’s stock valued at $75,000 after purchasing an additional 1,903 shares during the last quarter. Integrated Advisors Network LLC acquired a new position in Soliton during the 4th quarter valued at about $165,000. Oxford Asset Management LLP acquired a new position in Soliton during the 4th quarter valued at about $209,000. Finally, First Republic Investment Management Inc. boosted its stake in Soliton by 75.2% during the 4th quarter. First Republic Investment Management Inc. now owns 48,000 shares of the company’s stock valued at $527,000 after purchasing an additional 20,600 shares during the last quarter. Institutional investors own 11.81% of the company’s stock.
